Physician profile
Rupal Bandi
NPI 1649242991
$3,694.87
in general payments reported to CMS, 2019-2025
15 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $1,263 · 2021: $44.07 · 2022: $877 · 2023: $583 · 2024: $377 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,250.00 | 2020 | |
| Access Vascular INC | $650.00 | 2022 | |
| Boston Scientific Corporation | $435.10 | 2019-2025 | Embold Fibered, Obsidio |
| Inari Medical, INC. | $272.59 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $149.84 | 2022-2023 | Hydropearl |
| Sirtex Medical INC | $146.79 | 2024-2025 | Sir-Spheres Microspheres |
| Bard Peripheral Vascular, INC. | $142.23 | 2019-2024 | |
| Galvanize Therapeutics, INC | $136.07 | 2023 | Aliya System |
| Ethicon US, LLC | $125.06 | 2022-2023 | Neuwave |
| Nevro Corp. | $117.70 | 2024 | Senza |
| Novo Nordisk INC | $80.07 | 2019 | |
| Becton, Dickinson and Company | $70.99 | 2019 | |
| Angiodynamics, INC. | $55.83 | 2019 | |
| Siemens Medical Solutions USA, INC. | $44.07 | 2021 | |
| Stryker Corporation | $18.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupal Bandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.